Analysis of sample-to-cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing

Transfusion

Volumn 50, Issue 6, 2010, Pages 1344-1351

  Kiely, Philip ^a   Walker, Kyall ^a   Parker, Susan ^a   Cheng, Anthea ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CHEMOLUMINESCENCE; CONTROLLED STUDY; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; LABORATORY DIAGNOSIS;

ANTIBODIES, VIRAL; AUSTRALIA; BLOOD DONORS; CHEMILUMINESCENT MEASUREMENTS; DONOR SELECTION; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOASSAY; MALE; VIRUS DISEASES;

EID: 77953088088     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02572.x     Document Type: Article

References (33)

1. Kiely P, Kay D, Parker S, Piscitelli L. The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. Transfusion 2004 44 : 349 58.
2. Abutaleb A, Abed E, Qasem L, Miemish ZA, Hajeer AH. Improved efficiency of a hepatitis C virus antibody testing algorithm in blood donors from Saudi Arabia. Br J Biomed Sci 2004 61 : 155 6.
3. Amorim RM, Oliveira CP, Wyant PS, Cerqueira DM, Camara GN, Flores LS, Martins RM, Martins CR. Hepatitis C virus genotypes in blood donors from the Federal District, Central Brazil. Mem Inst Oswaldo Cruz 2004 99 : 895 7.
4. Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR, Zhu FM, Tiemuer MH, Bai XH, Shan H. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005 45 : 1816 22.
5. Echevarria JM, Avellon A, Jonas G, Hausmann M, Vockel A, Kapprell HP. Sensitivity of a modified version of the ARCHITECT anti-HCV test in detecting samples with immunoblot-confirmed, low-level antibody to hepatitis C virus. J Clin Virol 2006 35 : 368 72.
6. Agha S, El-Mashad N, El-Malky M, El-Shony H, El-Sherif MZ, El-Hasan MA, Tanaka Y, Mizokami M. Prevalence of low positive anti-HCV antibodies in blood donors: schistosoma mansoni co-infection and possible role of autoantibodies. Microbiol Immunol 2006 50 : 447 52.
7. Barreto AM, Takei K, Sabino EC, Bellesa MA, Salles NA, Barreto CC, Nishiya AS, Chamone DF. Cost-effective analysis of different algorithms for the diagnosis of hepatitis C virus infection. Braz J Med Biol Res 2008 41 : 126 34.
8. Contreras AM, Tornero-Romo CM, Toribio JG, Celis A, Orozco-Hernandez A, Rivera PK, Mendez C, Hernandez-Lugo MI, Olivares L, Alvarado MA. Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion 2008 48 : 2540 8.
9. Schroter M, Schafer P, Zollner B, Polwka S, Laufs R, Feucht HH. Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay. J Med Virol 2001 64 : 320 4.
10. Polywka S, Schroter M, Feucht HH, Zollner B, Laufs R. Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol 2001 39 : 1665 8. (Pubitemid 32275491)
11. Dufour DR, Talastas M, Fernandez MD, Harris B. Chemiluminescence assay improves specificity of hepatitis C antibody detection. Clin Chem 2003 49 : 940 4.
12. Dufour DR, Talastas M, Fernandez MDA, Harris B, Strader DB, Seef LB. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem 2003 49 : 479 86.
13. Oethinger M, Mayo DR, Falcone J, Barua PK, Griffith BP. Efficiency of the Ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios. J Clin Microbiol 2005 43 : 2477 80.
14. Vermeersh P, Van Ranst M, Lagrou K. Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory. J Clin Virol 2008 42 : 394 8.
15. Centers for Disease Control and Prevention. Guidelines for laboratory testing and results reporting of antibody to hepatitis C virus. MMWR 2003 52 : 1 15.
16. Berger A, Rabenau H, Allwinn R, Doerr HW. Evaluation of the new ARCHITECT anti-HCV screening test under routine laboratory conditions. J Clin Virol 2008 43 : 158 61.
17. Kim S, Kim JH, Yoon S, Park YH, Kim HS. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Micbriol 2008 46 : 3919 23.
18. Nelson KE, Shan H. Confirmatory testing of hepatitis C virus-positive enzyme immunoassay results in limited-resource countries: should it be attempted? Transfusion 2008 48 : 1239 44.
19. Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays. Transfusion 2003 43 : 226 34.
20. Mison L, Seed CR, Margaritis AR, Hyland C the ARCBS NAT Study Group. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. Vox Sang 2003 84 : 11 9.
21. Kleinman SH, Stramer SL, Brodsky JP, Caglioti S, Busch MP. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms. Transfusion 2006 46 : 695 702.
22. Kiely P, Stewart Y, Castro L. Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management. Transfusion 2003 43 : 584 90.
23. Kiely P, Thomas B, Kebede M. Long term serologic followup of donors with biological false reactivity on an anti-human T-cell lymphotropic virus types I and II chemiluminescent immunoassay and implications for donor management. Transfusion 2008 48 : 1833 41.
24. Kiely P, Miller K, Denham-Ricks P, Kebede M. Unusually strong, but transient, non-specific human immunodeficiency virus types 1 and 2 antibody reactivity. Transfusion 2008 48 : 1521 2.
25. Laperche S, Morel P, Deschaseaux M, Bouchardeau F, Alimardani G, Guillaume N, Rouger P, Lefrere, JJ. HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation. Transfusion 2003 43 : 1428 32.
26. Stramer SL. Viral diagnostics in the arena of blood donor screening. Vox Sang 2004 87 Suppl 2 : S180 3.
27. Madec Y, Boufassa F, Rouzioux C, Delfraissy JF, Meyer L. Undetectable viremia without antiretroviral therapy in patients with HIV seroconversion: an uncommon phenomenon? Clin Infect Dis 2005 40 : 1350 4.
28. Fiebig EW, Heldebrant CM, Smith RI, Conrad AJ, Delwart EL, Busch MP. Intermittent low-level viremia in very early primary HIV-1 infection. J Acquir Immune Defic Syndr 2005 39 : 133 7.
29. Hatano H, Delwart EL, Norris PJ, Tzong-Hae L, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM, Martin JN, Busch MP, Deeks SG. Evidence for persistent low-level viremia in individuals who control HIV in the absence of antiretroviral therapy. J Virol 2009 83 : 329 35.
30. Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002 100 : 2637 41.
31. Kleinman SH, Kuhns MC, Todd DS, Glynn SA, McNamara A, DiMarco A, Busch MP for the Retrovirus Epidemiology Donor Study. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003 43 : 696 704.
32. Kleinman SH, Strong DM, Tegtmeier GGE, Holland PV, Gorlin JB, Cousins CR, Chiacchierini RP, Pietrelli LA. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion 2005 45 : 1247 57.
33. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBC: implications for future HBV screening policy. Transfusion 2004 44 : 1332 9.